Search Results - "Okerholm, R A"

Refine Results
  1. 1

    Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation by Yun, C H, Okerholm, R A, Guengerich, F P

    Published in Drug metabolism and disposition (01-05-1993)
    “…The antihistaminic drug terfenadine, alpha-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1- piperidinebutanol (Seldane), is of interest because of…”
    Get more information
    Journal Article
  2. 2

    The Pharmacokinetics of Sodium Oxybate Oral Solution following Acute and Chronic Administration to Narcoleptic Patients by Borgen, Lowell A., Okerholm, Richard A., Lai, Allen, Scharf, Martin B.

    Published in Journal of clinical pharmacology (01-03-2004)
    “…This trial was conducted to evaluate the pharmacokinetics and safety of a sodium oxybate (gamma‐hydroxybutyrate [GHB]) oral solution in narcoleptic patients…”
    Get full text
    Journal Article
  3. 3

    Determination of the metabolites of terfenadine in human urine by thermospray liquid chromatography-mass spectrometry by Chen, T M, Chan, K Y, Coutant, J E, Okerholm, R A

    “…Thermospray liquid chromatography-mass spectrometry (TSP LC-MS) was used to determine human urinary metabolites of terfenadine after oral administration of…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Pharmacokinetics of vigabatrin following single and multiple oral doses in normal volunteers by Hoke, J F, Yuh, L, Antony, K K, Okerholm, R A, Elberfeld, J M, Sussman, N M

    Published in Journal of clinical pharmacology (01-05-1993)
    “…The pharmacokinetics of vigabatrin were investigated after single and multiple oral doses in two groups of 24 healthy male volunteers. Vigabatrin was well…”
    Get more information
    Journal Article
  6. 6

    Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure by Smith, N A, Kates, R E, Lebsack, C, Ruder, M A, Mead, R H, Bekele, T, Okerholm, R A, Rubin, G M, Winkle, R A

    Published in The American heart journal (01-09-1991)
    “…Twenty-one patients with heart failure (New York Heart Association [NYHA] class II to IV) received a 24-hour infusion of enoximone followed by a 12-hour…”
    Get more information
    Journal Article
  7. 7

    Pharmacology and pharmacokinetics of enoximone by Dage, R C, Okerholm, R A

    Published in Cardiology (01-01-1990)
    “…Enoximone is an inotropic vasodilating agent. Its principal effects are positive inotropism and vasodilation, which are not accompanied by changes in…”
    Get more information
    Journal Article
  8. 8

    Pharmacokinetics of terfenadine in healthy elderly subjects by Eller, M G, Walker, B J, Westmark, P A, Ruberg, S J, Antony, K K, McNutt, B E, Okerholm, R A

    Published in Journal of clinical pharmacology (01-03-1992)
    “…The pharmacokinetics of the terfenadine active metabolite, metabolite I, was examined in ten healthy elderly adults and ten younger adults after single-dose…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Bioavailability of terfenadine in man by Okerholm, R A, Weiner, D L, Hook, R H, Walker, B J, Leeson, G A, Biedenbach, S A, Cawein, M J, Dusebout, T D, Wright, G J, Myers, M, Schindler, V, Cook, C E

    Published in Biopharmaceutics & drug disposition (01-04-1981)
    “…Fourteen normal male subjects were given either 60mg or 180mg of terfenadine suspension in a randomized two-way crossover study. Peak plasma concentrations of…”
    Get more information
    Journal Article
  11. 11

    Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure by Uretsky, Barry F., Generalovich, Thomas, Reddy, P.S., Salerni, Rosemarie, Valdes, Anita M., Spangenberg, Robert B., Lang, James F., Okerholm, Richard A.

    Published in The American journal of cardiology (01-08-1984)
    “…MDL 17,043, when administered intravenously in humans, produces a significant and salutary hemodynamic response. To determine its acute effect when…”
    Get full text
    Journal Article
  12. 12

    Absence of food effects on the pharmacokinetics of terfenadine by Eller, M G, Walker, B J, Yuh, L, Antony, K K, McNutt, B E, Okerholm, R A

    Published in Biopharmaceutics & drug disposition (01-04-1992)
    “…Administration of terfenadine (Seldane) immediately after a high fat breakfast slightly affects the rate but not the extent of absorption relative to fasting…”
    Get more information
    Journal Article
  13. 13

    Human serum and plasma protein binding of enoximone and its sulfoxide metabolite by Hook, R H, Boxenbaum, H, Thompson, G A, Okerholm, R A

    Published in Journal of pharmaceutical sciences (01-12-1988)
    “…Experimental factors and determinants of the protein binding of enoximone (a new cardiotonic agent) were investigated in human serum from healthy, drug-free…”
    Get more information
    Journal Article
  14. 14

    Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol by Gupta, S K, Okerholm, R A, Eller, M, Wei, G, Rolf, C N, Gorsline, J

    Published in Journal of clinical pharmacology (01-05-1995)
    “…This randomized, crossover study compared the nicotine and cotinine pharmacokinetic parameters and plasma concentration profiles of two different nicotine…”
    Get more information
    Journal Article
  15. 15

    Method of analysis of the new cardiotonic agent, MDL 19,205, in plasma and urine and its application in a dog pharmacokinetic study by Keeley, F J, Theile, J D, Garteiz, D A, Weiner, D L, Okerholm, R A

    Published in Journal of chromatography (01-01-1983)
    “…A high-performance liquid chromatographic method has been developed for the analysis of plasma and urine concentrations of a new cardiotonic agent, MDL 19,205…”
    Get more information
    Journal Article
  16. 16

    Quantitative analysis of melperone in human plasma by gas chromatography--mass spectrometry--selected ion monitoring by Chan, K Y, Okerholm, R A

    Published in Journal of chromatography (01-01-1983)
    “…A sensitive, specific and reliable assay utilizing a combined gas chromatography--mass spectrometry--selected ion monitoring technique is described for the…”
    Get more information
    Journal Article
  17. 17

    Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System) by Gupta, S K, Okerholm, R A, Coen, P, Prather, R D, Gorsline, J

    Published in Journal of clinical pharmacology (01-02-1993)
    “…The pharmacokinetics and tolerability of single and multiple applications of Nicotine Transdermal Systems (NTS), designed to deliver 14 mg of nicotine per 24…”
    Get more information
    Journal Article
  18. 18

    Radioimmunoassay for terfenadine in human plasma by Cook, C E, Williams, D L, Myers, M, Tallent, C R, Leeson, G A, Okerholm, R A, Wright, G J

    Published in Journal of pharmaceutical sciences (01-12-1980)
    “…A radioimmunoassay procedure was developed for the antihistamine terfenadine…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection by Coutant, J E, Westmark, P A, Nardella, P A, Walter, S M, Okerholm, R A

    Published in Journal of chromatography (18-09-1991)
    “…This work describes the methodology for the analysis of terfenadine and the acid metabolite of terfenadine in plasma using high-performance liquid…”
    Get more information
    Journal Article